FDA 483 - Michael Gordon MD - March 16, 2012

An FDA inspection of Michael Gordon MD, a clinical investigator in San Diego, CA, revealed issues with study conduct and record keeping. The firm failed to ensure an investigator agreement was signed prior to subject enrollment and maintained incomplete subject case histories.